BridgeMD
New treatment option for Permeability; Increased
Official title Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet.
ClinicalTrials.gov ID: NCT05477212
What this study is testing
- What it's testing
- This study is open label, with one arm only. In this study will be enrolled patients with obesity (BMI more than 30).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- BMI ≥ 30 Kg/m2 or abdominal circumference (waist) \>94 cm in men and \>80 cm in women (IDF criteria for the definition of abdominal obesity) with or...
- Age range between 18 and 70 years, both sexes
- Diagnosis of hepatic steatosis, formulated on the basis of fibroscan [CAP (controlled attenuation parameter) \> 238 dB/m(decibel/meter)], and other...
You likely can't join if
- Normal and underweight people
- Presence of any pathology that may affect the presence of altered intestinal permeability or steatosis, apart from pathologies that represent...
- Treatment with any device, pharmacological or not, that can affect intestinal permeability and liver metabolism and, therefore, the presence of...
- Pregnancy or lactation
The study team makes the final eligibility decision.
Where it's taking place
- Castellana Grotte, BARI, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Castellana Grotte, BARI, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.